Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2024CancersOpen Access

Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

IVIlaria VigliottaIstituto di Ematologia di BolognaVSVincenza SolliIstituto di Ematologia di BolognaSASilvia ArmuzziIstituto di Ematologia di Bologna

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vigliotta et al. (2024) studied this question.

synapsesocial.com/papers/68e5b296b6db64358754c40fhttps://doi.org/10.3390/cancers16172929
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases2022 · 13 citations
  2. 2Regression models for the analysis of longitudinal Gaussian data from multiple sources2005 · 13 citations
  3. 3Molecular profiling of single circulating tumor cells with diagnostic intention2014 · 259 citations
  4. 4Liquid biopsy technologies for hematological diseases2020 · 51 citations
  5. 5Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma2022 · 118 citations